Biopharma Group

Biopharma Group Contract Manufacturing & Development (CDMO) Profile

Biopharma Group are a worldwide leading CDMO who specialises in liquid and drying technologies. With over 30 years of experience in the pharma and biotech sectors, we have helped global companies to characterise their materials, scale-up processes, troubleshoot products, develop cycles, take products from R&D through to early clinical phases and more. Our expertise covers various product types, including small molecules, large molecules, recombinant proteins, vaccines, ADCs, cells, and microorganisms, making us well-equipped to cater to any of your needs. In addition to lyophilisation, we also provide support within areas such as liquid fill finish, formulation development and stability screening.

CDMO Services:
Finished Dosage Forms (Small Molecule Drugs); Biologics; Cell & Gene Therapy; Medical Devices Cartridges; Liquids; Lyophilized amps/vials; Semi-solids; Soft Gels; Sterile Vials Analytical Development; Drug Delivery System; Formulation Development; Process Development Antibodies; Antibody-drug conjugate (ADC); Fusion Proteins; Recombinants + other Proteins; mRNA Vaccines; Protein Vaccines; Live Viral Vaccines; Viral Vector Vaccines; Plasmid DNA; Live Biotherapeutic Products

Year Founded: 1989

Head Office: Winchester, United Kingdom

Number of Facilities: 1-2

Facility locations: Europe; North America

Website: Visit the Biopharma Group website

Linkedin: Connect on Linkedin

Current Capacity: Over 25 freeze dryers on-site, GMP lab, 3 Low bioburden labs, cytotoxic suite and manufacturing/production facility.